arrow
M

Marianne Chase

Harvard Medical School
H指数:12
被引数:1,138

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

ENLITE PD: A Randomized Clinical Trial of Light Therapy for Impaired Sleep in Parkinson's Disease

ENLITE PD:一项针对帕金森病患者睡眠障碍的光疗随机临床试验

2025-09-060
PRE
Multicenter Expanded Access Protocol for Research Through Access to Trehalose in People With Amyotrophic Lateral Sclerosis

多中心扩展性访问方案:通过向肌萎缩侧索硬化症患者提供海藻糖进行研究

2025-08-260
OAAI
Operational Development and Launch of an Adaptive Platform Trial in Amyotrophic Lateral Sclerosis: Processes and Learnings From the First Four Regimens of the HEALEY ALS Platform Trial

在肌萎缩侧索硬化症中适应性平台试验的运营发展与启动:HEALEY ALS平台试验前四项方案的过程与经验

2025-05-260
OA
Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis, A Randomized Clinical Trial

Zilucoplan治疗肌萎缩侧索硬化症的疗效与安全性:一项随机临床试验

2025-02-173
OA
CNM-Au8 in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial

CNM-Au8在肌萎缩侧索硬化症中的应用:HEALEY ALS平台试验

2025-02-173
PRE
Verdiperstat in Amyotrophic Lateral Sclerosis Results From the Randomized HEALEY ALS Platform Trial

维德帕司他(Verdiperstat)在肌萎缩侧索硬化症中的效果:随机HEALEY ALS平台试验结果

2025-02-172
PRE
Evidence for Survival Benefit in ALS with CNM-Au8 Treatment Across Three Study Populations
2023-04-250
PRE
Results from the first four regimens of the HEALEY ALS Platform Trial
2023-04-250
PRE
Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trial
2022-05-1651
OAAI
Prospective biomarker study in newly diagnosed glioblastoma: Cyto-C clinical trial

新诊断胶质母细胞瘤的前瞻性生物标志物研究: Cyto-C临床试验

2021-12-241
OAAI
Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical Trial

加压素1a拮抗剂SRX246在易激惹亨廷顿舞蹈病患者中的安全性和耐受性-一项随机2期临床试验

2020-11-1618
OAAI
Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis
2020-09-03345
OAAI